Copeland Capital Management LLC decreased its stake in LeMaitre Vascular, Inc. (NASDAQ: LMAT) by 5.0% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 940,328 shares of the medical instruments supplier's stock after selling 49,709 shares during the

AWM Investment Company Inc. lowered its position in shares of LeMaitre Vascular, Inc. (NASDAQ: LMAT) by 10.3% in the second quarter, according to the company in its most recent filing with the SEC. The firm owned 130,000 shares of the medical instruments supplier's stock after selling 15,000 shares during the quarter. AWM Investment

High coverage ratios and earnings growth make CAH, LTH, LMAT and FLS safer investment bets heading into 2026.

LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

The final trades of the day with CNBC's Melissa Lee and the 'Fast Money' traders.

BURLINGTON, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in three upcoming investor conferences.

LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.

LeMaitre Vascular, Inc. ( LMAT ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants Dorian LeBlanc - Chief Financial Officer George LeMaitre - Chairman & CEO David Roberts - President & Director Conference Call Participants Michael Sarcone - Jefferies LLC, Research Division Shaymus Contorno - Oppenheimer & Co. Inc., Research Division Rick Wise Nathan Treybeck - Wells Fargo Securities, LLC, Research Division Michael Petusky - Barrington Research Associates, Inc., Research Division Brett Fishbin - KeyBanc Capital Markets Inc., Research Division James Sidoti - Sidoti & Company, LLC Kyle Bauser - ROTH Capital Partners, LLC, Research Division Daniel Stauder - Citizens JMP Securities, LLC, Research Division Presentation Operator Hello. Good day. This is RJ, your conference operator today, and we welcome you to the LeMaitre Vascular, Inc. Q3 2025 Financial Results Conference Call.

LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.49 per share a year ago.